A recombinant fungal compound induces anti-proliferative and pro-apoptotic effects on colon cancer cells

Oncotarget

Volumn 8, Issue 17, 2017, Pages 28854-28864

  Nimri, Lili ^a   Spivak, Orly ^a   Tal, Dana ^a   Schälling, Dominik ^b   Peri, Irena ^a   Graeve, Lutz ^b   Salame, Tomer M ^a   Yarden, Oded ^a   Hadar, Yitzhak ^a   Schwartz, Betty ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b UNIVERSITY OF HOHENHEIM   (Germany)

Author keywords

Colon cancer; Fungal; Microtubule; Pro apoptotic; Recombinant ostreolysin

Indexed keywords

ANTINEOPLASTIC AGENT; BETA TUBULIN; FUNGAL PROTEIN; RECOMBINANT OSTREOLYSIN; UNCLASSIFIED DRUG; HEMOLYSIN; OSTREOLYSIN; RECOMBINANT PROTEIN; TUBULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL MEMBRANE; CELL VIABILITY; COLON CANCER; CONTROLLED STUDY; CYTOSOL; DRUG EFFICACY; DRUG MECHANISM; DRUG PENETRATION; DRUG TARGETING; HCT 116 CELL LINE; HUMAN; HUMAN CELL; IN VIVO STUDY; INTESTINE EPITHELIUM CELL; MALE; MOUSE; NONHUMAN; PLEUROTUS OSTREATUS; TUMOR GROWTH; TUMOR VOLUME; TUMOR XENOGRAFT; ANIMAL; C57BL MOUSE; CELL PROLIFERATION; COLON TUMOR; DRUG EFFECT; DRUG SCREENING; GENETICS; IMMUNOLOGY; METABOLISM; MOLECULARLY TARGETED THERAPY; NUDE MOUSE; PATHOLOGY; PLEUROTUS;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL PROLIFERATION; COLONIC NEOPLASMS; FUNGAL PROTEINS; HCT116 CELLS; HEMOLYSIN PROTEINS; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, NUDE; MOLECULAR TARGETED THERAPY; PLEUROTUS; RECOMBINANT PROTEINS; TUBULIN; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 85018423658     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.15859     Document Type: Article

References (33)

1. Brenner H, Stock C and Hoffmeister M. Colorectal cancer screening: the time to act is now. BMC Med. 2015; 13:262
2. Lauber K, Bohn E, Krober SM, Xiao YJ, Blumenthal SG, Lindemann RK, Marini P, Wiedig C, Zobywalski A, Baksh S, Xu Y, Autenrieth IB, Schulze-Osthoff K, et al. Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. Cell. 2003; 113:717-730
3. Adams JM and Cory S. The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene. 2007; 26:1324-1337
4. Lowe SW, Cepero E and Evan G. Intrinsic tumour suppression. Nature. 2004; 432:307-315
5. Perez EA. Microtubule inhibitors: Differentiating tubulin-inhibiting agents based on mechanisms of action, clinical activity, and resistance. Mol Cancer Ther. 2009; 8:2086-2095
6. Gottesman MM. Mechanisms of cancer drug resistance. Annu Rev Med. 2002; 53:615-627
7. Pellegrini F and Budman DR. Review: tubulin function, action of antitubulin drugs, and new drug development. Cancer Invest. 2005; 23:264-273
8. Cohen R, Persky L and Hadar Y. Biotechnological applications and potential of wood-degrading mushrooms of the genus Pleurotus. Appl Microbiol Biotechnol. 2002; 58:582-594
9. Kues U and Liu Y. Fruiting body production in Basidiomycetes. Appl Microbiol Biotechnol. 2000; 54:141-152
10. Berne S, Krizaj I, Pohleven F, Turk T, Macek P and Sepcic K. Pleurotus and Agrocybe hemolysins, new proteins hypothetically involved in fungal fruiting. Biochim Biophys Acta. 2002; 1570:153-159
11. Berne S, Sepcic K, Anderluh G, Turk T, Macek P and Poklar Ulrih N. Effect of pH on the pore forming activity and conformational stability of ostreolysin, a lipid raft-binding protein from the edible mushroom Pleurotus ostreatus. Biochemistry. 2005; 44:11137-11147
12. Sepcic K, Berne S, Potrich C, Turk T, Macek P and Menestrina G. Interaction of ostreolysin, a cytolytic protein from the edible mushroom Pleurotus ostreatus, with lipid membranes and modulation by lysophospholipids. Eur J Biochem. 2003; 270:1199-1210
13. Zuzek MC, Macek P, Sepcic K, Cestnik V and Frangez R. Toxic and lethal effects of ostreolysin, a cytolytic protein from edible oyster mushroom (Pleurotus ostreatus), in rodents. Toxicon. 2006; 48:264-271
14. Fan JY, Carpentier JL, van Obberghen E, Grunfeld C, Gorden P and Orci L. Morphological changes of the 3T3-L1 fibroblast plasma membrane upon differentiation to the adipocyte form. J Cell Sci. 1983; 61:219-230
15. Ota K, Leonardi A, Mikelj M, Skocaj M, Wohlschlager T, Kunzler M, Aebi M, Narat M, Krizaj I, Anderluh G, Sepcic K and Macek P. Membrane cholesterol and sphingomyelin, and ostreolysin A are obligatory for pore-formation by a MACPF/CDC-like pore-forming protein, pleurotolysin B. Biochimie. 2013; 95:1855-1864
16. Tomita T, Noguchi K, Mimuro H, Ukaji F, Ito K, Sugawara-Tomita N and Hashimoto Y. Pleurotolysin, a novel sphingomyelin-specific two-component cytolysin from the edible mushroom Pleurotus ostreatus, assembles into a transmembrane pore complex. J Biol Chem. 2004; 279:26975-26982
17. Parton RG and Simons K. The multiple faces of caveolae. Nat Rev Mol Cell Biol. 2007; 8:185-194
18. Valverde ME, Hernandez-Perez T and Paredes-Lopez O. Edible mushrooms: improving human health and promoting quality life. Int J Microbiol. 2015; 2015:376387
19. Lavi I, Levinson D, Peri I, Nimri L, Hadar Y and Schwartz B. Orally administered glucans from the edible mushroom Pleurotus pulmonarius reduce acute inflammation in dextran sulfate sodium-induced experimental colitis. Br J Nutr. 2010; 103:393-402
20. Lavi I, Friesem D, Geresh S, Hadar Y and Schwartz B. An aqueous polysaccharide extract from the edible mushroom Pleurotus ostreatus induces anti-proliferative and proapoptotic effects on HT-29 colon cancer cells. Cancer Lett. 2006; 244:61-70
21. Chowdhury HH, Rebolj K, Kreft M, Zorec R, Macek P and Sepcic K. Lysophospholipids prevent binding of a cytolytic protein ostreolysin to cholesterol-enriched membrane domains. Toxicon. 2008; 51:1345-1356
22. Sepcic K, Berne S, Rebolj K, Batista U, Plemenitas A, Sentjurc M and Macek P. Ostreolysin, a pore-forming protein from the oyster mushroom, interacts specifically with membrane cholesterol-rich lipid domains. FEBS Lett. 2004; 575:81-85
23. Skocaj M, Resnik N, Grundner M, Ota K, Rojko N, Hodnik V, Anderluh G, Sobota A, Macek P, Veranic P and Sepcic K. Tracking cholesterol/sphingomyelin-rich membrane domains with the ostreolysin A-mCherry protein. PLoS One. 2014; 9:e92783
24. Jordan MA. Mechanism of action of antitumor drugs that interact with microtubules and tubulin. Curr Med Chem Anticancer Agents. 2002; 2:1-17
25. Asp N, Pust S and Sandvig K. Flotillin depletion affects ErbB protein levels in different human breast cancer cells. Biochim Biophys Acta. 2014; 1843:1987-1996
26. Banning A, Kurrle N, Meister M and Tikkanen R. Flotillins in receptor tyrosine kinase signaling and cancer. Cells. 2014; 3:129-149
27. Orrenius S. Mitochondrial regulation of apoptotic cell death. Toxicol Lett. 2004; 149:19-23
28. Oliver FJ, de la Rubia G, Rolli V, Ruiz-Ruiz MC, de Murcia G and Murcia JM. Importance of poly(ADP-ribose) polymerase and its cleavage in apoptosis. Lesson from an uncleavable mutant. J Biol Chem. 1998; 273:33533-33539
29. Lu X, Li C, Wang YK, Jiang K and Gai XD. Sorbitol induces apoptosis of human colorectal cancer cells via p38 MAPK signal transduction. Oncol Lett. 2014; 7:1992-1996
30. Tirapu I, Arina A, Mazzolini G, Duarte M, Alfaro C, Feijoo E, Qian C, Chen L, Prieto J and Melero I. Improving efficacy of interleukin-12-transfected dendritic cells injected into murine colon cancer with anti-CD137 monoclonal antibodies and alloantigens. Int J Cancer. 2004; 110:51-60
31. Nimri L, Saadi J, Peri I, Yehuda-Shnaidman E and Schwartz B. Mechanisms linking obesity to altered metabolism in mice colon carcinogenesis. Oncotarget. 2015; 6:38195-38209. doi: 10.18632/oncotarget.5561
32. Yehuda-Shnaidman E, Nimri L, Tarnovscki T, Kirshtein B, Rudich A and Schwartz B. Secreted human adipose leptin decreases mitochondrial respiration in HCT116 colon cancer cells. PLoS One. 8:e74843. doi: 10.18632/oncotarget.2453
33. Algamas-Dimantov A, Yehuda-Shnaidman E, Hertz R, Peri I, Bar-Tana J and Schwartz B. Prevention of diabetespromoted colorectal cancer by (n-3) polyunsaturated fatty acids and (n-3) PUFA mimetic. Oncotarget. 2014; 5:9851-9863